SCHEMBL9512235

SCHEMBL9512235

Oc1c(-c2ccccc2)cc(-[n+]2c(-c3ccccc3)cc(-c3ccccc3)cc2-c2ccccc2)cc1-c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 10/20 0.61
NPC1 O15118 9/20 0.61
NTSR1 P30989 3/20 0.61
NR2F2 P24468 1/20 0.61
RAD52 P43351 1/20 0.61
HTT P42858 3/20 0.61
MAPK1 P28482 2/20 0.61
NPSR1 Q6W5P4 2/20 0.61
KDM4E B2RXH2 1/20 0.61
UHRF1 Q96T88 1/20 0.61
KMT2A Q03164 4/20 0.49
MEN1 O00255 3/20 0.49
MAPT P10636 2/20 0.49
LMNA P02545 1/20 0.49
NPY1R P25929 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
RCE1 Q9Y256 1/20 0.49
CRHBP P24387 2/20 0.48
CRHR2 Q13324 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL23198666 0.98 NPC1 (0.64) RAB9ANPC1NTSR1NR2F2RAD52
Perchlorate SCHEMBL9508583 0.95 RAB9A (0.70) RAB9ANPC1NTSR1NR2F2RAD52
SCHEMBL23198667 0.95 RAB9A (0.56) RAB9ANPC1NTSR1NR2F2RAD52
SCHEMBL13698931 0.87 RAB9A (0.49) RAB9ANPC1NTSR1NR2F2RAD52
SCHEMBL14164148 0.86 NPC1 (0.51) RAB9ANPC1NTSR1NR2F2RAD52
Trifluoromethanesulfonic Acid SCHEMBL23198662 0.85 NPC1 (0.50) RAB9ANPC1NTSR1NR2F2RAD52
SCHEMBL9290152 0.83 NPC1 (0.48) RAB9ANPC1NTSR1NR2F2RAD52
SCHEMBL158977 0.82 NPC1 (0.66) RAB9ANPC1NTSR1NR2F2RAD52
SCHEMBL14356289 0.82 NPC1 (0.61) RAB9ANPC1NTSR1NR2F2RAD52
SCHEMBL11988997 0.81 RAB9A (0.55) RAB9ANPC1NTSR1NR2F2RAD52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0226543-B1 PROCESS FOR THE PREPARATION OF GLYCIDYL COMPOUNDS CIBA-GEIGY AG (CH) 1993-09-29 EP claimed
CN-107205893-B Emulsions stabilized by amphiphilic composite particles 莱雅公司 2022-02-18 CN disclosed
EP-3802555-A1 IONIC METAL ALKYLIDENE COMPOUNDS AND USE THEREOF IN OLEFINIC METATHESIS REACTIONS Verbio Vereinigte BioEnergie AG (DE) 2021-04-14 EP disclosed
CN-107205893-A Pass through the emulsion that amphiphilic composite particles are stable 莱雅公司 2017-09-26 CN disclosed
EP-2057275-B1 ARRAY FOR RAPID DETECTION OF A MICROORGANISM KIMBERLY CLARK CO (US) 2017-02-01 EP disclosed
US-8871232-B2 Self-indicating wipe for removing bacteria from a surface KIMBERLY-CLARK WORLDWIDE, INC. (US) 2014-10-28 US disclosed
CN-102317760-B Apparatus and method for optical sensing of a substance or environmental condition RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) 2014-10-22 CN disclosed
US-20130224866-A1 MEDICAL FLUID ACCESS DEVICE WITH ANTISEPTIC INDICATOR BAXTER HEALTHCARE S.A. (CH) 2013-08-29 US disclosed
US-8431086-B2 Medical fluid access device with antiseptic indicator BAXTER INTERNATIONAL INC. (US) 2013-04-30 US disclosed
US-8431086-B2 Medical fluid access device with antiseptic indicator BAXTER INTERNATIONAL INC. (US) 2013-04-30 US disclosed
US-20080021381-A1 MEDICAL FLUID ACCESS DEVICE WITH ANTISEPTIC INDICATOR BAXTER INTERNATIONAL INC. (US) 2008-01-24 US disclosed
US-7300770-B2 Detection of microbe contamination on elastomeric articles KIMBERLY-CLARK WORLDWIDE, INC. (US) 2007-11-27 US disclosed
US-20070249012-A1 Microbial Detection and Quantification KIMBERLY-CLARK WORLDWIDE, INC. (US) 2007-10-25 US disclosed
US-7282349-B2 Solvatochromatic bacterial detection KIMBERLY-CLARK WORLDWIDE, INC. (US) 2007-10-16 US disclosed
US-7282349-B2 Solvatochromatic bacterial detection KIMBERLY-CLARK WORLDWIDE, INC. (US) 2007-10-16 US disclosed
WO-2007070181-A1 METHOD FOR SCREENING FOR BACTERIAL CONJUNCTIVITIS KIMBERLY-CLARK WORLDWIDE, INC. (US) 2007-06-21 WO disclosed
US-20070140971-A1 Method for screening for bacterial conjunctivitis KIMBERLY-CLARK WORLDWIDE, INC. 2007-06-21 US disclosed
US-7198777-B2 Optical contrast agents for optically modifying incident radiation THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2007-04-03 US disclosed
WO-2007027899-A1 SOLVATOCHROMIC VISUAL INDICATOR AND THE USE OF THE SAME KIMBERLY-CLARK WORLDWIDE, INC. (US) 2007-03-08 WO disclosed
US-20070048503-A1 graphic and/or message display system has a hidden graphic or message on an indicator panel; revealed when an obscuring graphic reacts with a solvent to change color; use on products to alert the wearer KIMBERLY-CLARK WORLDWIDE, INC. 2007-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070140971-A1 Method for screening for bacterial conjunctivitis TLR8, TLR3, TLR4 RAB9A 2555/4885NPC1 4273/4885NTSR1 2434/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.